CAN MONEY REDUCE HIV RISK?? Audrey Pettifor, PhD MPH Department of Epidemiology, University of North Carolina

Similar documents
REDUCING STRUCTURAL BARRIERS TO SCHOOLING: A MEANS TO REDUCE HIV RISK?

WOMEN & HIV: A GLOBAL UPDATE. Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

Effects of Cash Transfers for the Prevention of HIV in Young South African Women

Sex and the Classroom: Can a Cash Transfer Program for Schooling decrease HIV infections?

Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel

Combination HIV Prevention

AFRICAN AND BLACK DIASPORA GLOBAL NETWORK ON HIV AND AIDS ABDGN AIDS 2012 HIGHLIGHTS

Where are we going after effectiveness studies?

Biomedical Prevention Update Thomas C. Quinn, M.D.

PEP and PrEP: AWAAC 2014

Combination prevention: Public health and human rights imperatives

Schooling, Income, and HIV Risk: Experimental Evidence from a Cash Transfer Program.

HIV In South Africa: Turning the Tide of the Epidemic

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

Biomedical Prevention in HIV

Antiretrovirals for HIV prevention:

Understanding the Impact of an HIV Intervention Package for Adolescents

Implementing Cash Transfers in the context of HIV/AIDS

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

Pre-exposure prophylaxis : Systemic and topical. Linda-Gail Bekker The Desmond Tutu HIV Centre UCT SA HIV ClniciansSociety Conference 2012

M2010 Pre-Conference Workshop, Pittsburgh 22 May 2010

Professor Thomas Quinn Johns Hopkins Center for Global Health, Maryland, USA

HIV Prevention. Recent Advances and Implications for the Caribbean

International Partnership for Microbicides

Overview of ARV-based prevention trials

ART and Prevention: What do we know?

HIV Prevention Strategies HIV Pre-exposure prophylaxis

Using anti-hiv drugs for prevention

HIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017

Schooling, Income, and HIV Risk: Some insights from cash transfer experiments

Strategic use of antiretroviral drugs to prevent HIV transmission

ART for prevention the task ahead

Dr Valérie Martinez-Pourcher

Can we treat our way out of the HIV epidemic?

Successful results of clinical trials

Novel HIV Prevention Methods for Women

Update on ARV based PrEP

HIV Treatment Evolution. Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare

EVIDENCE-BASED SOCIAL PROTECTION INTERVENTIONS FOR HIV PREVENTION

Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City

The Big Picture: The current and evolving HIV prevention landscape

Biomedical HIV Prevention & TaP Treatment as Prevention 2013

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

Building Long-term Capacity for HIV/AIDS in Africa: S-S and Regional Strategies

Multiple choice questions: ANSWERS

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready

Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials:

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV?

Technical Guidance for Global Fund HIV Proposals

Psychosocial Issues in ART and HIV Prevention. Steven A. Safren, PhD

PEP and PREP. Dr David Hawkins Chelsea and Westminster Hospital

Antivirals and Vaccines: What s old and new in HSV-2 treatment

Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

Is this the end of AIDS? New advances in HIV prevention. James McIntyre Anova Health Institute and University of Cape Town School of Public Health

Downloaded from:

HIV: A global perspective on epidemiology, diagnosis and prevention

Translating the Science to End New HIV Infections in Kenya

EHPSA Adolescents Portfolio

Money, Sex, and Power: An Analysis of Relationship Power in the Context of Conditional Cash Transfer Interventions to Reduce Risky Sex in Tanzania

Program to control HIV/AIDS

Understanding the Results of VOICE

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

Review of planned trials and key emerging issues for Thailand

ARVs for prevention in at-risk populations: Microbicides

PrEP in young African women: Rationale & lessons from HPTN 082 (and other studiesp

Transmission Networks & Risk of HIV Infection in Young Women in KwaZulu-Natal, South Africa

On the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda

Schooling, Income, and HIV Risk (Malawi) Analytic Design. November 29, 2007

The Big Picture: The current and evolving HIV prevention landscape

Can money prevent the spread of HIV? A review of cash payments for HIV prevention

The Open Label Trial Past and Present

PREPARING FOR PREP: FROM KEY POPULATIONS THEORY TO PRACTICE. Dr Oscar Radebe

UNAIDS 2018 THE YOUTH BULGE AND HIV

Pre-Exposure Prophylaxis (PrEP) 1 Prevention of HIV in At-Risk Women:

HIV Clinical Update- HIV prevention

Impacts of Social Cash Transfers in sub- Saharan Africa: Evidence from the Transfer Project

A Daily Pill to Prevent HIV: Oral Pre-exposure Prophylaxis (PrEP)

Population Council Strategic Priorities Framework

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

Enrollment of high risk men in Africa

Children and AIDS Fourth Stocktaking Report 2009

Treatment as Prevention in India: What will it take?

The Science behind Preexposure Prophylaxis (PrEP) Yunus Moosa Department of Infectious Diseases UKZN

The Open Label Trial Past and Present

Update on PrEP progress: WHO/UNAIDS challenges and actions

The Government of Kenya s Cash Transfer Program Reduces the Risk of Sexual Debut among Young People Age 15-25

Partnerships between UNAIDS and the Faith-Based Community

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

Why should AIDS be part of the Africa Development Agenda?

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

ViiV Healthcare s Position on Prevention in HIV

DREAMS. Heather Watts M.D. Senior Technical Advisor Office of the US Global AIDS Coordinator US Department of State

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

PrEP: Pre Exposure Prophylaxis

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

Cash transfers and HIV/HSV-2 prevalence A replication of a cluster randomized trial in Malawi October Replication Paper 12

Transcription:

CAN MONEY REDUCE HIV RISK?? Audrey Pettifor, PhD MPH Department of Epidemiology, University of North Carolina

Overview Epidemiology of HIV in young people Rationale behind cash transfers Review completed and current studies that provide cash to to reduce HIV risk

Young people are at high risk Young People as Percent of Global Number of New HIV Infections, 2009 Under 15 14% Aged 25 + 51% Aged 15-24 35% New Infections = 2.6 million NOTE: Calculations are estimates. SOURCE: Kaiser Family Foundation calculations based on UNAIDS, Core Slides: Report on Global AIDS Epidemic, 2010.

Gender inequity is large in SSA HIV Prevalence among Young People (age 15-24) in sub-saharan Africa SOURCE: UNAIDS, Human Rights and Gender Equality. Global Report, 2010.

HIV prevalence by age and gender among South Africans age 15-24 55% 50% 45% 40% 35% Males Females 95% Confidence Interval 31.2% 30% 25% 25.0% 28.9% 26.3% 20% 15% 10% 9.4% 13.8% 14.4% 7.9% 12.2% 11.0% 5% 2.3% 4.1% 3.6% 4.0% 2.1% 6.0% 2.0% 2.6% 4.1% 5.8% 0% 15 16 17 18 19 20 21 22 23 24 SOURCE: Pettifor A, et al. AIDS 2005, 19: 1525-1534.

Adolescent HIV in the U.S. Estimated New HIV Infections in US (2006) Age Group Black/ African American Hispanic/Latino White Male No. % No. % No. % 13-29 6,760 42 3,010 41 4,050 25 30-39 4,170 26 2,520 34 5,600 34 40-49 3,680 23 1,410 19 4,640 29 50 1,510 9 480 6 1,980 12 Female 13-29 2,810 32 820 36 1,050 32 30-39 2,670 30 720 31 1,060 32 40-49 2,360 27 440 19 840 25 50 960 11 320 14 360 11 Note: Data have been adjusted for reporting delay. Data presented on blacks/african Americans, Hispanics/Latinos and whites only. SOURCE: CDC, HIV Incidence, 2006.

High risk behaviors not observed We found that young South African women do not report engaging in high risk sexual activity, despite the incredibly high incidence and prevalence of HIV among young women. Structural produce strong and consistent associations with HIV risk in young women. Few interventions have addressed structural barriers or rigorously evaluated them.

Wassserheit July 2008

Clinical trial evidence for preventing sexual HIV transmission 14 July 2011 Study Treatment for prevention (Africa, Asia, America s) PrEP for discordant couples (Partners PrEP) PrEP for heterosexuals (Botswana TDF2) Medical male circumcision (Orange Farm, Rakai, Kisumu) PrEP for MSMs (America s, Thailand, South Africa) STD treatment (Mwanza) Microbicide (CAPRISA 004 tenofovir gel) HIV Vaccine (Thai RV144) Effect size (CI) 96% (73; 99) 73% (49; 85) 63% (21; 48) 54% (38; 66) 44% (15; 63) 42% (21; 58) 39% (6; 60) 31% (1; 51) 0% 10 20 30 40 50 60 70 80 90 100% Efficacy

Few successes in HIV prevention Biomedical interventions show promise however they will require behavioral and structural changes to work What role do incentives and cash play in the prevention landscape?

Cash to prevent HIV Infection 2 main approaches to the issue Upstream-- Cash for poverty alleviation which aims to reduce HIV risk Cash as an incentive for behavior change (ie, money to test for HIV, for negative STI tests, to take your ART) Will both approaches work the same in different populations? What is the implication for scale up of both approaches?

Cash Transfers to keep young women in school In Mexico, the Oportundides program, which provides conditional cash transfers to poor families to send their children to school, has found that the program increases school enrollment, particularly for girls (Schultz T IFPRI 2000) Children in South African households that receive government social welfare grants are more likely to attend school and the observed effects are greater for young women than young men (Samson M et al. 2004) the greatest benefit of social welfare grants on educational outcomes appears to be for young women from the poorest households

Education and HIV: protection or risk? Data from early in the epidemic suggested that more education was associated with increased risk of HIV infection Two recent reviews on HIV and education indicate a protective association between higher education and HIV infection, particularly as epidemics mature (Hargreaves et al. AIDS 2008, Jukes et al. AIDS 2008)

Barriers to Education Costs associated with school are a major barrier In South Africa, 65% of young people who were not in school indicated that they did not have enough money to continue their education Hidden costs: uniforms, books/supplies, transport, food, etc. Young women are often taken out of school to find employment to support the family or to care for children or sick family members. Family commitments cited as barrier by 9% of non-school attending South African females, as opposed to <1% of nonattending males Samson M et al. The social and economic impact of South Africa s social security system. 2004

Why target girls? HIV incidence highest in young women Barriers to school attendance and drop out appear greater for girls than boys Observed effects on education and HIV are greater for girls than boys Programs that have reduced barriers to education have had greater effects for girls than boys

Evidence on CTs and HIV prevention To date we have identified 14 studies that are using cash transfers or incentives and are examining the impact on HIV risk reduction The majority are focused in SSA and in young people The majority are focused on upstream factors (ie, poverty alleviation) Seems to be growth of interventions aimed on downstream factors (ie, incentives for testing)

CT Evidence Type 1 Evaluation of existing government Cash Transfer programs on HIV risk behaviors Handa R01- Kenya OVC study

Current Evidence; Type 1 (study) Schooling Income and HIV Risk (SIHR) Malawi PI: Berk Ozler (World Bank), Sarah Baird (GWU), and Craig McIntosh (UCSD) Overview: 176 enumeration areas in Zomba (3796 girls ages 13-22 years, not married). 3 arms : conditional cash transfers, unconditional transfers, control. Amount to parent varied from USD 4-10 per month. Amount to girl varied from USD 1-5 per month. Results: Higher rates of school enrollment after 1 year (95% in intervention vs. 89% in control); lower rates of HIV prevalence after 18 months (1.2% in intervention vs. 3% in control); lower rates of HSV-2 infection after 18 months (0.7% in intervention vs. 3% in control); younger sexual partners (2 year difference in intervention vs. 3 year in control) No difference between conditional and unconditional arm. Change in partnership characteristics appeared to drive reduction in risk. Baird SJ, Garfein RS, McIntosh CT, Ozler B. Lancet. 2012 Feb 14. [Epub ahead of print]

Ongoing Studies- Type 1 (2) HPTN 068, Swa Koteka South Africa PI: Audrey Pettifor (UNC), Catherine MacPhail (WRHI), Kathleen Kahn (AHPU) Overview: RCT to examine effect of cash transfer conditional on school attendance. Young women ages13-20 years old (grades 9-11) and their parent guardian each receive a monthly payment. Primary endpoint is HIV and HSV-2 incidence in young women. Reducing HIV in Adolescents (CAPRISA 007) South Africa PI: Quarraisha Abdool Karim (CAPRISA) Overview: RCT. Cash transfers to boys and girls, school based. Incentives for school performance, HIV testing, etc. Primary endpoint HIV incidence.

Evidence Type 2 PI: Damian dewalque (World Bank), Will Dow Overview: Unblinded, individually randomized trial. 2399 participants 18-30 randomized to control arm or one of tow intervention arms- low value CCT ($10 per testing round) or high value CCT ($20 per testing round). Participants tested every 4 months over 12 month period for common STIs. CCT tied to negative STI tests. Results: At the end of 12 months, for combined prevalence of 4 STIs (CT, NG, TV and M genitalium) RR for high value CCT was 0.73 (95% CI 0.47-0.99.) No significant reduction observed for the low value CCT. No impact of either observed at month 4 or 8 month. de Walque D, et al. BMJ Open. 2012 Feb 8;2:e000747. Print 2012

Summary Cash transfers are increasingly being used and tested in the field of HIV prevention and care Different approaches to these programs (upstream vs downstream) Stay tuned for effects of programs on HIV incidence